Cargando…
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
Chemotherapy has been the traditional backbone for the management of metastatic lung cancer. Multiple trials have shown the benefits of treatment with platinum doublets in lung cancer. This “one treatment fits all” approach was further refined by the introduction of targeted agents and discovery of...
Autores principales: | Vadakara, Joseph, Borghaei, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513233/ https://www.ncbi.nlm.nih.gov/pubmed/23226067 http://dx.doi.org/10.2147/PGPM.S24258 |
Ejemplares similares
-
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
por: Aggarwal, Charu, et al.
Publicado: (2009) -
Treatment Paradigms for Advanced Non‐Small Cell Lung Cancer at Academic Medical Centers: Involvement in Clinical Trial Endpoint Design
por: Aggarwal, Charu, et al.
Publicado: (2017) -
How to Treat EGFR-Mutated Non–Small Cell Lung Cancer
por: Belani, Neel, et al.
Publicado: (2023) -
Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
por: Jiang, Wenxiao, et al.
Publicado: (2021) -
Crizotinib in the treatment of non-small-cell lung carcinoma
por: Płużański, Adam, et al.
Publicado: (2013)